Loading company…
Nijmegen company developing PLASOMA, a patented cold plasma system for healing chronic wounds such as diabetic foot ulcers.
Founded in 2013 in Nijmegen, Netherlands, Plasmacure BV sells PLASOMA, a patented cold plasma technology that delivers bactericidal plasma directly to chronic wounds, particularly diabetic foot ulcers. Its customers are hospitals and clinics, which buy the system as an initial investment. Plasmacure has completed 2 deals and raised EUR 6 million in Series A funding on June 8, 2025, from investors including Venture Medical, LLC, the European Innovation Council and Noaber Foundation. Bas Zeper is CEO and a co-founder.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in